Please login to the form below

Not currently logged in
Email:
Password:

Anthim

This page shows the latest Anthim news and features for those working in and with pharma, biotech and healthcare.

FDA approves new drugs from Teva, Lilly and Elusys

FDA approves new drugs from Teva, Lilly and Elusys

Cinqair, Taltz and Anthim have all been given the green light in the US. ... Finally, the FDA has also approved Elusys' Anthim (obiltoxaximab), an injectable treatment for anthrax infections caused by breathing in the bacterium Bacillus anthracis.

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop...

Latest intelligence

The communication challenge of helping he next generation to be healthier
As the pressure on the health service increases the health of the next generation is vital for everyone. How do we show positive attitudes and change behaviour while future proofing...
Are we losing sight of what the democratisation of healthcare really looks like?
We have a core responsibility as healthcare communicators to consistently drive for better inclusion, engagement and compliance. What does the ‘democratisation of healthcare’ really look like?...
William Kilgallon
How the Royal Society’s EiR programme can help to drive UK innovation
...